Roche To Start Phase 3 Study For Alzheimer's Prospect This Year After New Data From Phase 2
Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...
pharmaphorum21h
FDA experts to vote on Spark's groundbreaking gene therapy
Advisers to the US regulator will meet today to discuss Spark Therapeutics' Luxturna, which could become the first gene therapy approved for an inherited disease in the US. However concerns about ...
Nature23h
Genetically Modified Organisms (GMOs): Transgenic Crops and Recombinant DNA Technology
expressed in corn seeds induces an immune response when fed to chickens Faster maturation Coho salmon A type 1 growth hormone gene injected into fertilized fish eggs results in 6.2% retention of ...